Perspective Therapeutics Inc (CATX)
AMEX
Fin d'année 31 Décembre 2023 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Return on Assets (%) | -40.651 | -68.049 | -61.089 | -38.155 | -8.57 | -10.785 | -11.973 | -59.633 |
Return on Equity (%) | -45.721 | -85.862 | -81.117 | -51.585 | -9.271 | -11.302 | -12.655 | -71.649 |
Return on Invested Capital (%) | -55.504 | -92.52 | -88.058 | -53.934 | -9.372 | -11.675 | -13.68 | -52.483 |
Operating Margin (%) | -129.427 | -113.118 | -70.331 | -35.599 | -33.691 | -67.365 | -206.503 | -2790.934 |
Net Profit Margin (%) | -129.658 | -113.304 | -70.481 | -35.713 | -33.721 | -67.365 | -206.503 | -3243.236 |
Book Value Per Share | 0.188 | 0.088 | 0.111 | 0.081 | 0.474 | 0.43 | 0.384 | 0.003 |
Earnings Per Share | -0.112 | -0.122 | -0.076 | -0.05 | -0.024 | -0.051 | -0.052 | -0.166 |
Cash Per Share | 0.108 | 0.047 | 0.079 | 0.035 | 0.45 | 0.393 | 0.148 | 0.033 |
Working Capital Per Share | 0.167 | 0.066 | 0.092 | 0.057 | 0.461 | 0.402 | 0.355 | 0.004 |
Operating Profit Per Share | 0.018 | 0.036 | 0.048 | 0.078 | 0.037 | 0.035 | 0.007 | 0.005 |
EBIT Per Share | -0.112 | -0.122 | -0.076 | -0.05 | -0.024 | -0.051 | -0.052 | -0.143 |
EBITDA Per Share | -0.112 | -0.122 | -0.076 | -0.05 | -0.024 | -0.051 | -0.052 | -0.143 |
Free Cash Flow Per Share | -0.102 | -0.118 | -0.072 | -0.049 | -0.022 | -0.051 | -0.052 | -0.165 |
Fin d'année 31 Décembre 2023 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Actions en circulation | 55,02M | 55,02M | 67,39M | 68,9M | 141,92M | 142,04M | 142,11M | N/A |
Fin d'année 31 Décembre 2023 | Sept 2022 | Mar 2023 | Juin 2023 | Sept 2023 | Déc 2023 | Mar 2024 | Juin 2024 | Sept 2024 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Actions en circulation | 142,11M | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Margin (%) | -236.925 | -526.079 | N/A | N/A | N/A | -3629.538 | N/A | N/A |
Net Profit Margin (%) | -236.925 | -17.984 | N/A | N/A | N/A | -3779.692 | N/A | N/A |
Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Capitalisation boursière | 213,58M |
Ratio cours/bénéfice | -4,98 |
Ratio prix/ventes | 161,79 |
Ratio prix/liquidités | 25,09 |
Ratio prix/valeur comptable | 3,08 |
Rendement de dividende | - |
Actions en circulation | 67,59M |
Volume moyen (1 semaine) | 1,31M |
Volume moyen (1 mois) | 1,15M |
Variation sur 52 semaines | -23,42% |
Plus haut sur 52 semaines | 19,05 |
Plus bas sur 52 semaines | 2,70 |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales